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Case Description: We found three young adult patients (34, 45, and 27 years old at onset) with ischemic cerebrovascular disease, all of whom had congenital plasminogen abnormalities but no other known risk factors. Hemostatic tests of all three patients revealed plasma plasminogen activities at almost one half of the normal level despite normal plasma plasminogen antigen levels. They were found to be heterozygotes with abnormal plasminogen (normal hemiparesis including the face. His mother and grandmother had also suffered from cerebrovascular disease. Neurological examinations showed dysarthria, left medial longitudinal fasciculus syndrome, and right pyramidal tract signs. Brain MRI revealed a lacunar infarct at the left ventral pons. Conventional risk factors for stroke (including hypertension, diabetes mellitus, and hyperlipidemia) were all negative.
Case 3
Patient 3, a 27-year-old man, was admitted because of recurrent episodes of weakness and paresthesia of the left limbs. These episodes began in November 1990, and each lasted approximately 10 minutes. His father had suffered from vertebrobasilar insufficiency since 40 years of age. On admission, he had mild dysarthria and mild left hemiparesis, which disappeared completely within 24 hours. There was no abnormality in computed tomography, MRI, electroencephalography, or cerebral angiography. A diagnosis of recurrent transient ischemic attack was made. No conventional risk factors for stroke were found.
Results
The screening assays of the coagulation and fibrinolysis studies shown in Table 1 (Fig   1, line 1) . Heterozygote should show four bands, but we consider that the lowest band represents two overlapping bands in these cases.
Next, PCR direct sequence analysis was performed to identify the mutation in the plasminogen gene. In all three patients, guanine in GCT coding for Ala-601 was replaced by adenine, resulting in the substitution of threonine for alanine in plasminogen. All three patients were heterozygotes with abnormal plasminogen (Fig 2,   panel 1) . Unfortunately, DNA analysis of other members of the patients' families could not be performed because consent was denied.
The DNA sample of homozygote used in Figs 1 Congenital plasminogen abnormalities have been reported in association with venous thrombosis that develops at a relatively young age.' However, it has not been previously associated with stroke except for two reports.10"11 Shinmyozu et al12 found no significant difference in the frequencies of plasminogen abnormality between patients with cerebral infarction and normal subjects. We have thus far encountered 29 patients with ischemic cerebrovascular disease of early adult onset (aged younger than 45 years) who have known plasminogen activity and plasminogen antigen levels. Among them, three (10.3%) have abnormal plasminogen but no other known risk factor. This frequency is markedly higher than that in the Japanese population (2% to 3%),12-14 implying that this abnormality may be an important risk factor for ischemic cerebrovascular disease in young adults. Available reports on juvenile ischemic cerebrovascular disease and abnormal plasminogen, including data on our patients, are listed in Table 2 .
The frequency of abnormal plasminogen is rather high in the Japanese population (2% to 3%)12-14 compared with other populations (1%). 15 We believe that examination for abnormal plasminogen should be made routinely in young adults presenting with ischemic cerebrovascular disease, especially in those without other known risk factors. 
